Nuvalent, Inc.
NUVL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $83,843 | $80,913 | $74,418 | $69,423 |
| G&A Expenses | $28,853 | $23,658 | $20,394 | $16,876 |
| SG&A Expenses | $28,853 | $23,658 | $20,394 | $16,876 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $112,696 | $104,571 | $94,812 | $86,299 |
| Operating Income | -$112,696 | -$104,571 | -$94,812 | -$86,299 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$9,609 | $5,063 | $10,387 | $11,707 |
| Pre-Tax Income | -$122,305 | -$99,508 | -$84,425 | -$74,592 |
| Tax Expense | $132 | $145 | $157 | $171 |
| Net Income | -$122,437 | -$99,653 | -$84,582 | -$74,763 |
| % Margin | – | – | – | – |
| EPS | -1.7 | -1.39 | -1.18 | -1.05 |
| % Growth | -22.3% | -17.8% | -12.4% | – |
| EPS Diluted | -1.7 | -1.39 | -1.18 | -1.05 |
| Weighted Avg Shares Out | 72,143 | 71,844 | 71,608 | 71,156 |
| Weighted Avg Shares Out Dil | 72,143 | 71,844 | 71,608 | 71,156 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,201 | $11,103 | $11,817 | $13,047 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$122,305 | -$104,571 | -$94,812 | -$86,299 |
| % Margin | – | – | – | – |